Worth reading
42Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
55
¥100 million (increase in ordinary income from the year-earlier period)Wording
Avoiding a definitive answer
How definitive the wording is.No category-specific facts could be extracted from this document.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Domestic agrochemicals, rice paddy herbicides and nursery-box treatment products, advance shipments of Axeev to the US, and bismaleimides for generative AI servers performed well. Ordinary income also benefited from an improvement in foreign exchange gains and losses and an increase in equity-method investment income.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.